Suomi -
suomi -
Fimea (Suomen lääkevirasto)
aldactone 25 mg tabletti, kalvopäällysteinen
pfizer oy pfizer oy - spironolactonum - tabletti, kalvopäällysteinen - 25 mg - spironolaktoni
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
aldactone 50 mg tabletti, kalvopäällysteinen
pfizer oy pfizer oy - spironolactonum - tabletti, kalvopäällysteinen - 50 mg - spironolaktoni
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
aldactone 100 mg tabletti, kalvopäällysteinen
pharmacia oy - spironolactonum - tabletti, kalvopäällysteinen - 100 mg - spironolaktoni
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastiset aineet - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - systeemiset bakteerilääkkeet, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.